Zusammenfassung
Als Pruritus wird eine anhaltende, verstärkte Juckreizempfindung verstanden, die zum Teil somatischen, zum anderen Teil aber auch psychogenen Ursprungs sein kann. Der Juckreiz ist keine spezifische Empfindungsqualität; er begleitet viele entzündliche Dermatosen und ist in der Regel auf eine unspezifische Reizung freier polymodaler Nervenendigungen (Nozirezeptoren) im Bereich der dermoepidermalen Basalzone zurückzuführen, nicht zuletzt als Folge der Ausschüttung entzündungsbedingter Mediatoren und von entzündlichem Begleitödem. Für die Übermittlung der Juckreizempfindung sind marklose, capsaicinsensitive Nervenfasern verantwortlich. Die Behandlung der juckenden Dermatose mit Minderung der entzündlichen Phänomene führt auch zur symptomatischen Linderung des Juckreizes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Abdel-Naser MB, Gollnick H, Orfanos CE (1993) Aquagenic pruritus as a presenting symptom of polycythemia vera. Dermatology 187:130–133
Asawalam B, Osifo NG, Haller L (1993) Drugs against chloroquine antimalarial itch. J Eur Acad Derm Venereol 2: 193–199
Bayoumi A-HM, Highet AS (1986) Baking soda baths for aquagenic pruritus. Lancet II: 464
Bernhard JD (1991) Pruritus: advances in treatment. In: Callen JP, Dahl MV, Golitz LE et al (eds) Advances in dermatology, vol 6. Mosby, St. Louis, pp 57–71
Breneman DL, Cardone JS, Blumsack RF et al. (1992) Topical capsaicin for treatment of hemodialysis-related pruritus. J Am Acad Dermatol 26: 91–94
Carson TE (1991) Aquagenic pruritus: effective treatment with intramuscular triamcinolone acetonide. Cutis 48:382
Cerio R, Murphy GM, Shaden GE, McDonald GM (1988) A combination of phototherapy and cholestyramine for the relief of pruritus in primary biliary cirrhosis. Br J Dermatol 116: 265–267
De Marchi S, Cecchin E, Villaita D et al. (1992) Relief of pruritus and decrease in plasma histamine concentrations during erythropoietin therapy in patients with uremia. N Engl J Med 326:969–974
Denman ST (1986) A review of pruritus. J Am Acad Dermatol 14:386–392
Duo LJ (1987) Electrical needle therapy of uremic pruritus. Nephron 47:179–183
Ellis CN, Berberian B, Sulica VI et al. (1993) A double-blind evaluation of topical capsaicin in pruritic psoriasis. J Am Acad Dermatol 29: 438–442
Fjellner B, Hägermark O (1982) Influence of ultraviolett light on itch and flare reactions in human skin induced by histamine and the histamine liberator compound 48/80. Acta Derm Venereol 62:137–140
Gall H, Kaufmann R, Ehr M von et al. (1993) Persistierender Pruritus nach Hydroxylstärken-Infusionen. Hautarzt 44: 713–716
Gilchrest BA, Stern RS, Steinman TI et al. (1982) Clinical features of pruritus among patients undergoing maintenance hemodialysis. Arch Dermatol 118:154–156
Gilchrest BA, Rowe JW, Brown RS et al. (1978) Relief of uremic pruritus with ultraviolet phototherapy. N Engl J Med 297:136–138
Greaves MW (1993) New pathophysiological and clinical insights into pruritus. J Dermatol 20:735–740
Hermann J, Gall H (1990) Diagnose und Therapie des persistierenden Pruritus nach Infusion von Hydroxylstärke (HÄS). Akt Dermatol 16: U66–U67
Kantor GR, Lookingbill DP (1983) Generalized pruritus and systemic disease. J Am Acad Dermatol 9:375–382
Kinloch de Loes S, Didierjean L, Rieckhoff-Canton L et al. (1991) Bullous pemphigoid autoantibodies and HIV-1 infections. AIDS 5: 451–454
Lorette G, Vaillant L (1990) Pruritus-current concepts in pathogenesis and treatment. Drugs 39: 218–223
Lotti T, Teofoli P, Tsampau D (1994) Treatment of aquagenic pruritus with topical capsaicin cream. J Am Acad Dermatol 30:232–235
May CD (1976) High spontaneous release of histamine in vitro from leukocytes of persons hypersensitivity to food. J Allergy Clin Immunol 58:432–437
Menagé Du HP, Norris PG, Hawk ILM, Greaves MW (1993) The efficacy of psorale photochemotherapy in the treatment of aquagenic pruritus. Br J Dermatol 129:163–165
Mettang T, Fritz P, Weber J et al. (1990) Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD) the role of plasma histamine and skin mast cells. Clin Nephrol 34:136–141
Okor RS (1990) Responsiveness of chloroquin-induced pruritus to antihistamine therapy: a clinical survey. J Clin Pharm Ther 15:147–150
Parker NE, Porter JB, Williams HJM, Leftley N (1982) Pruritus after administration of hetastarch. Br Med J 284:385–386
Runne O, Orfanos CE (1977) Cutaneous neural proliferation in highly pruritic lesions of chronic prurigo. Arch Dermatol 113:787–791
Stähle-Bäckdahl M (1992) Pruritus in hemodialysis patients. Skin Pharmacol 5:14–20
Stockenhuber F, Kurz RW, Serti K, Grimm G, Balcke P (1990) Increased plasma histamine levels in uraemic pruritus. Clin Sci 79:477–482
Swerlick RA (1985) Photochemotherapy treatment for pruritus associated with polycythaemia vera. J Am Acad Dermatol 13: 675–677
Tapia L, Cheigh JS, David DS et al. (1977) Pruritus in dialysis patients treated with parenteral lidocaine. N Engl J Med 296:261–262
Hann SK, Cho MY, Park YK (1990) UV treatment of generalized prurigo nodularis. Int J Dermatol 29: 436–437
Harris B, Harris K, Penneys NS (1992) Demonstration by S-100 protein staining of increased numbers of nerves in the papillary dermis of patient with prurigo nodularis. J Am Acad Dermatol 26:56–58
Hirtschel-Scholz S, Salomon D, Merot Y, Saurat JH (1991) Anetodermic prurigo nodularis (with Pautrier’s neuroma) responsive to arotinoid acid. J Am Acad Dermatol 25: 437–442
Linhardt PW, Walling AD (1993) Prurigo nodularis. J Fam Pract 37:495–198
Payne R, Wilkinson JD, Mckee PH, Jurecka W, Black MM (1985) Nodular prurigo — a clinopathological study of 46 patients. Br J Dermatol 113: 431–439
Peresz GL, Peters MS, Reda AM, Butterfiled JH, Peterson EA, Leitermann KM (1993) Mast cells, Neutrophils, and Eosinophils in Prurigo nodularis. Arch Dermatol 129: 861–865
Runne U, Orfanos CE (1977) Cutaneous neural proliferation in highly pruritic lesions of chronic prurigo. Arch Dermatol (Chicago) 113:787–791
Tupker RA, Coenraads PJ, van der Meer JB (1992) Treatment of prurigo nodularis, chronic prurigo and neurodermatitis circumscripta with topical capsaicin. Acta Derm Venerol (Stockholm) 72: 463–465
Väätäinen N, Hannuksela M, Karvonen J (1979) Local photo-chemotherapy in nodular prurigo. Acta Derm Venerol (Stockholm) 59:544–547
Winkelmann RK, Connolly SM, Doyle JA, Padilha-Concalves A (1984) Thalidomide treatment of prurigo nodularis. Acta Derm Venerol (Stockholm) 64:412–417
Ädelroth E, Rak S, Haahtela T et al. (2000) Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergical rhinits. J Allergy Clin Immunol 106: 253–259
Aram H (1987) Cimetidine in Dermatology. Int J Dermatol 26:161–166
Bateman DN, Chapman PH, Rawlins MD (1983) The effects of astemizole on histamine-induced wheal and flare. Eur J Clin Pharmacol 25:547–551
Berth-Jones J, Graham-Brown RA (1989) Failure of terfenadine in relieving the pruritus of atopic dermatitis. Br J Dermatol 121: 635–637
Brooks CD, Karl KJ (1988) Hay fever treatment with combined antihistamine and cyclooxygenase-inhibiting drugs. J Allergy Clin Immunol 81:1110–1117
Campbell AM, Bousquet J (1993) Anti-allergic activity of H1-blockers. Int Arch Allergy Immunol 101: 308–310
Coulie P, De Vos C, Ghys L, Rihoux JP (1989) Pharmacologic modulation by cetirizine 2 HCl and loratadine of the histamine-induced skin reaction in mice and humans. Drug Dev Res 17:199–206
Coulie P, Wery M, Rihoux JP (1989) Pharmacologic modulation of cetirizine — 2HCl on cutaneous reactions and pruritus in man after experimental mosquito bites. Skin Pharmacol 2:38–40
Dahinden CA, Krieger M, Brunner T et al. (1991) Factors promoting histamine and leukotriene release. In: Ring J, Przybilla B (eds) New trends in allergy, vol III. Springer, Berlin Heidelberg New York, pp 138–142
Diller G, Orfanos CE (1983) Behandlung der idiopathischen Urticaria mit H1 + H2-Antagonisten. Ergebnisse einer Crossover Doppelblind-Langzeitstudie. Z Hautkr 58: 785–793
Dupont C, Maubeuge J de, Kotlar W et al. (1984) Oxatomide in the treatment of pruritus senilis. A double-blind placebocontrolled trial. Dermatologica 169:348–353
Fadel R, Herpin-Richard N, Rihoux JP, Henocq E (1987) Inhibitory effect of cetirizine 2 HCl on eosinophil migration in vivo. Clin Allergy 17:373–379
Francos GC, Kauh YC, Gittlen SD et al. (1991) Elevated plasma histamine in chronic uremia. Effects of ketotifen on pruritus. Int J Dermatol 30: 884–889
Frosch PJ, Schwanitz HJ, Macher E (1984) A double blind trial of H1 and H2 receptor antagonists in the treatment of atopic dermatitis. Arch Dermatol Res 276:36–40
Geha RS, Meltzer EO (2001) Desloratadine: A new, non sedating oral antihistamine. J Allergy Clin Immunol 107:751–762
Gengo FM, Gabos C (1987) Antihistamines, drowsiness, and psychomotor impairment: central nervous system effect of cetirizine. Ann Allergy 59:53–57
Hägermark Ö, Wahlgren CF, Giös I (1992) Inhibitory effect of loratadine and clemastine on histamin release in human skin. Skin Pharmacol 5:93–98
Ichinose AV, Belvisi MG, Barnes PJ (1990) Histamines H3 receptors inhibit neurogenic microvascular leakage in airway. J Appl Physiol 68: 21–25
Jankowski R, Wagenmann M, Baroody FM, Naclerio R (1993) Effect of terfenadine on nasal provocation. Int Arch Allergy Immunol 101:311–317
Knowles S, Shear NH (1989) Antihistamines. Clin Dermatol 7:48–59
Kobza Black A (1992) H1-Antagonists in the management of the itch of urticarias. Skin Pharmacol 5: 21–24
Kobza Black A, Aboobaker J, Gibson JR et al. (1988) Acrivastine versus hydroxyzine in the treatment of cholinergic urticaria. Acta Derm Venereol 68: 541–544
Krause L, Schuster S (1983) Mechanism of action of antipruritic drugs. Br Med J Clin Res 287:1199–1200
Krause LB, Shuster (1985) A comparison of astemizole and chlorpheniramine in dermographic urticaria. Br J Dermatol 112: 447–453
Milgrom H, Fick Jr RB, Su JQ et al. (1999) Treatment of allergic asthma with monoclonal anti-IgE antibody rhuMAb-E25 Study Group. N Engl J Med 341:1966–1973
Milsmann E, Rohdewald P (1985) Placebo-controlled study on the efficacy of topical antihistamines against hista-mine-induced pruritus. Dermatologica 170: 230–234
Mitsuhashi M, Payan DG (1992) Functional diversity of histamine and histamine receptors. J Invest Dermatol 98 [Suppl]: 85–115
Monroe EW (1988) Chronic urticaria: Review of non sedating H1 antihistamines in treatment. J Am Acad Dermatol 19:842–849
Naclerio RM, Kagey-Sobotka A, Lichtenstein LM et al. (1990) Terfenadine, an H1-antihistamine, inhibits histamine release in vivo in the human. Am Rev Respir Dis 142: 167–171
Okor RS (1990) Responsiveness of chloroquine-induced pruritus to antihistamine therapy. J Clin Pharm Ther 15: 147–150
Paul E, Bodeker RH (1986) Treatment of chronic urticaria with terfenadine and ranitidine. Europ J Clin Pharmacol 31: 277–280
Rakowski J, Neumann Y (1989) Loratadin: Ein neues Antihistaminikum. Arzneimitteltherapie 7:95–98
Rihoux JP, Dupont P (1987) Comparative study of the peripheral and central effects of terfenadine and cetirizine 2 HCl. Ann Allergy 59: 235–238
Rihoux JP, Dupont P (1989) Pharmacological modulation by astemizole and cetirizine 2 HCl of the skin reactivity to histamine. Acta Therapeutica 15: 265–270
Saihan EM (1981) Ketotifen and terbutaline in urticaria. Br J Dermatol 104: 205–206
Schultze-Werninghaus G (1990) Cetirizin — ein neues nicht sedierendes Antihistaminikum. Arzneimitteltherapie 8: 346–349
Sharpe GR, Shuster S (1993) In dermographic urticaria H2 receptor antagonists have a small but therapeutic irrelevant additional effect compared with H1 antagonists alone. Br J Dermatol 129:575–579
Shin MS, Baroody F, Proud D et al. (1992) The effect of azelastine on the early allergic response. Clin Exp Allergy 22: 289–295
Sigler RW, Evans R, Horakova Z et al. (1980) The role of cyproheptadine in the treatment of cold urticaria. J Allergy Clin Immunol 65:309–312
Simons FE (1990) Recent advances in H1 receptor antagonist treatment. J Allergy Clin Immunol 86:995–999
Wahlgren CF, Hägermark Ö, Bergstrom R, Hedin B (1988) Evaluation of a new method of assessing pruritus and antipruritic drugs. Skin Pharmacol 1:3–13
Wahlgren CF, Hägermark Ö, Bergstrom R (1990) The antipruritic effect of a sedative and a non-sedative antihistamine in atopic dermatitis. Br J Dermatol 122:545–551
Wahn U, Zielen S, Schuer U et al. (2001) Omalizumab (Xolair, rhuMAb-E25) plus specific immunotherapy in children with seasonal allergic rhinitis is superior to specific immunotherapy alone. Allergy 56, Suppl. 68: 61
Watson WTA, Simons KJ, Chen XY, Simons FER (1989) Cetirizin: a pharmacodynamic evaluation in children with seasonal allergic rhinitis. J Allergy Clin Immunol 84: 457–464
Weck de AL, Derer T, Bischoff SC, Takafuji S (1993) The effect of terfenadine on the immediate and late-phase reactions mediated by immunoglobulin E. Int Arch Allergy Immunol 101:326–332
Werner RJ, Marsch WC (1992) Therapie einer Druckurti-karia vom verzögertem Typ mit Cetirizin. Dermatol Monatsschr 178:187–190
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Orfanos, C.E., Garbe, C. (2002). Pruritus — Antihistaminika und Antiallergica. In: Blume-Peytavi, U., et al. Therapie der Hautkrankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56219-8_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-56219-8_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62541-1
Online ISBN: 978-3-642-56219-8
eBook Packages: Springer Book Archive